Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

February 2, 2020Open Access

Development and validation of the Cambridge Multimorbidity Score

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The Cambridge Multimorbidity Score is robust and can be either tailored or not tailored to specific health outcomes. It will be valuable to those planning clinical services, policymakers allocating resources and researchers seeking to account for the effect of multimorbidity.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Development and validation of the Cambridge Multimorbidity Score | Synapse

Cite This Study

Payne et al. (Sun,) studied this question.

synapsesocial.com/papers/69dcc304f3d3790cb7133a94 https://doi.org/https://doi.org/10.1503/cmaj.190757

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Predicting risk of emergency admission to hospital using primary care data: derivation and validation of QAdmissions score2013 · 127 citations
2A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation1987 · 50,008 citations
3Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity2015 · 171 citations
4A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology2012 · 1,172 citations
5Validation of ACG Case-mix for equitable resource allocation in Swedish primary health care2009 · 40 citations